HopeStage
Back to all studies
CompletedNCT02167620

Metformin for Diabetes Risk in People With Serious Mental Illness

About this titleRead the official source — NCT02167620
Placebo comparisonAges 17–45CanadaSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 17 years to 45 years.

Listed locations
TorontoSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2014
Recruitment status
Completed
Enrollment listed in the registry
35
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 17 Years to 45 Years
Official registry ID
NCT02167620
Official title
Show the full official title

Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Metformin and Placebo.

Who was this study for?

Listed age limits: 17 years to 45 years.

Want to explore more studies?

Explore studies